Learn About Large-Cell Immunoblastic Lymphoma

What are the alternative names for Large-Cell Immunoblastic Lymphoma?
  • Large cell immunoblastic lymphoma
Save information for later
Sign Up
Who are the top Large-Cell Immunoblastic Lymphoma Local Doctors?
TH
Dr. Thomas M. Habermann
Hematology | Hematology Oncology
Elite
Highly rated in
27
conditions
Hematology
Hematology Oncology

Rochester, Minnesota

Rochester, MN 

Thomas Habermann is a Hematologist and a Hematologist Oncology doctor in Rochester, Minnesota. Dr. Habermann has been practicing medicine for over 43 years and is rated as an Elite doctor by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. He is also highly rated in 27 other conditions, according to our data. His top areas of expertise are Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma, and B-Cell Lymphoma. He is board certified in Hematology and Hematology/oncology and licensed to treat patients in Minnesota. Dr. Habermann is currently accepting new patients.

View Profile
JA
James O. Armitage
Dr. James O. Armitage
Hematology | Oncology | Hematology Oncology
Elite
Highly rated in
26
conditions
Hematology
Oncology
Hematology Oncology

Cancer Center At Village Pointe Health Center

Omaha, NE 

James Armitage is a Hematologist and an Oncologist in Omaha, Nebraska. Dr. Armitage has been practicing medicine for over 49 years and is rated as an Elite doctor by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. He is also highly rated in 26 other conditions, according to our data. His top areas of expertise are Diffuse Large B-Cell Lymphoma, Non-Hodgkin Lymphoma, Large-Cell Immunoblastic Lymphoma, and B-Cell Lymphoma. He is board certified in Hematology and Medical Oncology and licensed to treat patients in Nebraska. Dr. Armitage is currently accepting new patients.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
LG
Dr. Leo I. Gordon
Hematology | Oncology
Elite
Highly rated in
25
conditions
Hematology
Oncology

Robert H Lurie Cancer Center

Chicago, IL 

Leo Gordon is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Gordon has been practicing medicine for over 49 years and is rated as an Elite doctor by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. He is also highly rated in 25 other conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Hodgkin Lymphoma, and Follicular Lymphoma. He is board certified in Hematology and licensed to treat patients in Illinois. Dr. Gordon is currently accepting new patients.

View Profile
View All Doctors
What are the latest Large-Cell Immunoblastic Lymphoma Clinical Trials?
Prospective, Multi-center Phase I/II Trial of Lenalidomide and Dose-Adjusted EPOCH-R in MYC-Associated B-Cell Lymphomas
Who is this study for: Adult patients with B Cell Lymphoma
Status: Active, not recruiting
Start Date: July 29, 2014
Intervention Type: Drug, Other, Biological
Study Drugs: Lenalidomide, Daunorubicin, Doxorubicin, Intensol, Podofilox, Etoposide, Rituximab
Phase: Phase 1/Phase 2
View Trial
Summary: This phase I/II trial studies the side effects and best dose of lenalidomide when given together with combination chemotherapy and to see how well they work in treating patients with v-myc myelocytomatosis viral oncogene homolog (avian) (MYC)-associated B-cell lymphomas. Lenalidomide may stop the growth of B-cell lymphomas by blocking the growth of new blood vessels necessary for cancer growth and...
Match to trials
Find the right clinical trials for you in under a minute
Get started
A Multicenter, Open-Label Feasibility Study of Daratumumab With Dose-Adjusted EPOCH in Newly Diagnosed Plasmablastic Lymphoma
Who is this study for: Patients with newly diagnosed plasmablastic lymphoma
Status: Recruiting
Start Date: May 24, 2021
Intervention Type: Drug, Biological
Study Drugs: Daunorubicin, Doxorubicin, Intensol, Daratumumab, Podofilox, Etoposide
Phase: Early Phase 1
View Trial
Summary: This feasibility trial studies how well daratumumab in combination with dose-adjusted etoposide, prednisone, vincristine sulfate, cyclophosphamide, and doxorubicin hydrochloride (DA-EPOCH) works in treating patients with newly diagnosed stage I-IV plasmablastic lymphoma. Plasmablastic lymphoma cells have high levels of a protein called CD38. Daratumumab is a monoclonal antibody that specifically t...
View All Clinical Trials
What are the Latest Advances for Large-Cell Immunoblastic Lymphoma?

There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.